What does COLLEGIUM PHARMACEUTICAL, INC (COLL) do?

COLLEGIUM PHARMACEUTICAL, INC (COLL) is a publicly traded company in the Healthcare sector.

What sector does COLL operate in?

COLLEGIUM PHARMACEUTICAL, INC operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find COLL earnings analysis?

AlphaOS publishes an earnings intelligence page for COLLEGIUM PHARMACEUTICAL, INC (COLL) covering results, guidance context, and AI-assisted analysis. See /stocks/COLL/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

COLL

COLLEGIUM PHARMACEUTICAL, INC

Healthcare · Pharmaceutical Preparations

$22.63Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

COLLEGIUM PHARMACEUTICAL, INC shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +6% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +6% YoY in Q2 FY2026

Pipeline evidence · 22d ago

COLL's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on COLL.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full COLL earnings analysis

Reported figures for COLLEGIUM PHARMACEUTICAL, INC — research only, not investment advice.

Revenue YoY: +6.3%
EPS YoY: -235.3%

Latest Intelligence

Updated September 28, 2026

What happened recently for COLLEGIUM PHARMACEUTICAL, INC (COLL) — events, not interpretation.

Event: Reported Q2 2026 revenue +6% YoY.
Also: Last session September 28, 2026 at $22.63.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for COLLEGIUM PHARMACEUTICAL, INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $736.73M
Revenue:: $199.88M

COLL earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow COLLEGIUM PHARMACEUTICAL, INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Pharmaceuticals90% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.